
*Corresponding author,
e-mail : yoga.ww@unpad.ac.id (Y. W. Wardhana)
https://doi.org/10.24198/idjp.v1i3.23508
© 2019 Wardhana et al
Vol 1, Issue 3, 2019 (74-78)
http://journal.unpad.ac.id/idjp
Dissolution Behaviours of Acetaminophen and Ibuprofen Tablet Inuenced By L–
HPC 21, 22, and Sodium Starch Glycolate as Disintegrant
Yoga W. Wardhana*, Dradjad Priambodo
Department Pharmaceutics and Pharmaceuticals Technology Faculty of Pharmacy, Universitas
Padjadjaran
Jl. Raya Bandung – Sumedang Km. 21 Jatinangor 45363, Sumedang, Indonesia
Received: 5 Sep 2019/Revised: 23 Sep 2019/Accepted: 23 Sep 2019/Published: 1 Oct 2019
ABSTRACT
The dissolution of tablets is one of a drug absorption determinant. Disintegrant agent has play an
important role on determining the dissolution of tablets. In this experiment, the dissolution behaviours
of Acetaminophen and Ibuprofen Tablet was studied using various disintegrant agent such as Low
substituted – Hydroxypropyl Cellulose (L–HPC) 21, L–HPC 22 and Sodium Starch Glycolate (SSG)
as comparator. Those disintegrant agents were used at three concentration (6%, 7% and 8%) for every
tablets formula. Tablets were made by wet granulation method and pressed using single punch 13
of weight and size (diameter and thickness), hardness, friability, disintegration time and dissolution.
Physically standards from tablets were in good condition, the standards of the weight and thickness
tablet with 8% L– HPC 21, 7% and 8% SSG. The conclusion of the study was the L–HPC has more
disintegrant character at hydrophilic active ingredients.
Keywords:
1. Introduction
Tablet dosage forms has widely used in global
composition of all compressed tablets should, in
fact, be designed to guarantee that they will readily
undergo both disintegration and dissolution in the
upper gastrointestinal (GI) tract.
Dissolution tests are used nowadays in a wide
variety of applications: to help identify which
formulations will produce the best results in the
clinic, to release products to the market, to
verify batch to batch reproducibility, and to help
identify whether changes made to formulations
or their manufacturing procedure after marketing
clinic. Further, dissolution tests can sometimes be
implemented to help determine whether a generic
version of the medicine can be approved or rejected
[3].
Dissolution tests can be used to predict the in
vivo performance of the dosage form when release
of the drug is the limiting factor in the absorption
complex factors, one of all is excipient selection in
tablet formulation [3].
Standard in vitro dissolution testing models
include two processes: the release of drug substance
from the solid dosage form and drug dissolution.
Drug release is determined by formulation factors
such as disintegration/dissolution of formulation
solid-state pro-perties of the substance (e.g., particle
surface area, polymorphism), and formula-tion
properties (e.g., wetting, solubilization). In vitro
dissolution testing should thus provide predictions
of both the drug release and the dissolution
processes in vivo. To reach this goal, the choice of